Austin can provide a one-stop solution for Antibody-Drug Conjugates (ADCs) manufacturing from antibody production to in-house toxin-linker CMC services and antibody bioconjugation for drug substance. This is supported by long-term chemical and biological experience. Capabilities also exist to provide cytotoxic fill-finish drug product manufacturing. For more information contact Austin Chemical. #manufacturing #chemical #experience
Austin Chemical is excited to attend TechConnect World Innovation Expo in Washington, DC on June 13-15, 2022. We are happy to discuss our technology and service offerings, logistic support, sourcing and procurement, and contractual distribution services. Please contact Austin Chemical if you would like to set an appointment. #innovation #technology #chemical #procurement #sourcing
Austin Chemical is happy to announce Pharma Tech Outlook has named Cerbios as a Top CMO of 2022. Cerbios is a highly qualified CDMO engaged in the development and manufacturing of API’s, HPAPI’s, ADC’s, and Biologics. For more information on Cerbios’ capabilities please contact Austin Chemical.
Austin Chemical is proud to announce Cerbios-Pharma SA, is officially announcing the near finalization of the structure for its new manufacturing building dedicated to High Potency Active Ingredients (HPAPI), which will host 2 additional cGMP production lines for Cytotoxic molecules and additional space for dedicated R&D and QC Labs. Cerbios is active in the HPAPI…
